WallStSmart

Arthur J Gallagher & Co (AJG)vsMarsh & McLennan Companies Inc (MMC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies Inc generates 75% more annual revenue ($26.45B vs $15.11B). AJG leads profitability with a 10.4% profit margin vs 0.2%. AJG appears more attractively valued with a PEG of 0.82. MMC earns a higher WallStSmart Score of 62/100 (C+).

AJG

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 5.5Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 0.76

MMC

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 4.0Value: 5.0Quality: 4.8
Piotroski: 3/9Altman Z: 1.67

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AJG5 strengths · Avg: 9.0/10
Revenue GrowthGrowth
31.0%10/10

Revenue surging 31.0% year-over-year

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Market CapQuality
$64.35B9/10

Large-cap with strong market position

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

MMC2 strengths · Avg: 8.5/10
Market CapQuality
$89.82B9/10

Large-cap with strong market position

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

AJG4 concerns · Avg: 2.3/10
Return on EquityProfitability
6.8%3/10

ROE of 6.8% — below average capital efficiency

P/E RatioValuation
41.6x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-10.7%2/10

Earnings declined 10.7%

Altman Z-ScoreHealth
0.762/10

Distress zone — elevated risk

MMC4 concerns · Avg: 4.0/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.674/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AJG

The strongest argument for AJG centers on Revenue Growth, Debt/Equity, Market Cap. Revenue growth of 31.0% demonstrates continued momentum. PEG of 0.82 suggests the stock is reasonably priced for its growth.

Bull Case : MMC

The strongest argument for MMC centers on Market Cap, Free Cash Flow.

Bear Case : AJG

The primary concerns for AJG are Return on Equity, P/E Ratio, EPS Growth. A P/E of 41.6x leaves little room for execution misses.

Bear Case : MMC

The primary concerns for MMC are PEG Ratio, Revenue Growth, EPS Growth. Thin 0.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

AJG profiles as a growth stock while MMC is a value play — different risk/reward profiles.

MMC carries more volatility with a beta of 0.75 — expect wider price swings.

AJG is growing revenue faster at 31.0% — sustainability is the question.

MMC generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

AJG scores higher overall (62/100 vs 62/100) and 31.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arthur J Gallagher & Co

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Arthur J. Gallagher & Co. (AJG) is an American global insurance brokerage and risk management services firm headquartered in Rolling Meadows, Illinois.

Marsh & McLennan Companies Inc

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh McLennan (formerly known as Marsh & McLennan Companies) is a global professional services firm, headquartered in New York City with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, Guy Carpenter, Mercer, and Oliver Wyman.

Want to dig deeper into these stocks?